EDEN WOOTEN: Open Payments
NPI 1245797331 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 10 payments from 9 companies in 2025. Trend: 2023 $1,494 · 2024 $2,121 · 2025 $404
Food & beverage: $311Education: $93
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 1 | $123 |
| Janssen Biotech, Inc. | 1 | $93 |
| Bard Peripheral Vascular, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: clonoSEQ, DARZALEX, Trek, IMJUDO, Xospata, NIKTIMVO, PREVYMIS, OJJAARA.
Industry payments across TX — which companies pay providers there.
